Navigation Links
Letter from Alliqua CEO, Dave Johnston, to Shareholders
Date:3/7/2013

sources, staff, and clinical evidence behind our products, as well as the strategic plan necessary to propel our company into a new phase of expansion for 2013 and beyond.

Moving Alliqua Forward in 2013: Increasing Revenues and Expanding the Product Portfolio

Our hydrogel technology – the same technology that gave us our marketed surgical dressings, SilverSeal® and HyDress® – is the backbone of our company and represents an enormous opportunity for growth in many ways. In 2013 we intend to roll out a strategy to leverage this technology platform.

First, we are in the process of hiring a select group of senior, proven, sales and marketing managers who, together with our existing talent, will strive to increase revenues from our marketed products:  Together, we intend to:

a)       open up new distribution channels

b)       drive demand in our current channels including the VA

c)       leverage the strong clinical data

Through these and the existing educational and marketing efforts that are already underway, we expect to see SilverSeal® and HyDress® revenues start to increase in the Q2-Q4 timeframe.

Second, we plan to utilize business development opportunities to expand our product offerings. Namely, we intend to:

a)       focus on in-licensing marketed transdermal products to fulfill our vision around leveraging the hydrogel in transdermal drug delivery use.  Initially, we intend to focus on wound healing associated with pain, dermatology, infection and cancer

b)       expand our portfolio beyond products with potential hydrogel application by endeavoring to in-license or acquire additional wound-care products

This 2013 direction is intended to provide some early wins, while building
'/>"/>

SOURCE Alliqua, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. HealthEconomics.Com Announces Newsletter Promoting Health Outcomes and Pharma Reimbursement Jobs
2. HealthEconomics.Com Presents Top News Stories in Pharma Reimbursement and Pricing from this Week's Newsletter
3. Topical BioMedics' Newsletter Dedicated to Natural Healing and Wellness--New Issue Available Online
4. First Warning Systems and Unicorp Biotech International Strategic Partner Letter of Intent Signed Breast Cancer Early Detection
5. Amarantus BioSciences Issues CEO Letter to Shareholders
6. Mangrove Partners Sends Letter to Stockholders of Nabi Biopharmaceuticals
7. Ronald L. Chez Files Amended 13D and Letter to the Board
8. Elsevier to Participate in SCOAP3 With the Journals Physics Letters B and Nuclear Physics B
9. Bacterin Receives Letter From NYSE MKT LLC Regarding Timely Notice of Record Date for 2012 Annual Meeting of Stockholders
10. Genesis Biopharma Issues Letter To Shareholders
11. NeoStems CEO Letter to Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 27, 2015 WuXi PharmaTech (Cayman) Inc. ... capability and technology platform company serving the global ... that an Investigational New Drug (IND) application for ... arthritis has been accepted for review by the ... In September 2012, MedImmune, the global biologics ...
(Date:3/26/2015)... Bioscience, Inc. (NASDAQ: ROKA ), a molecular ... for the detection of foodborne pathogens, today reported ... full year ended December 31, 2014. ... ended December 31, 2014 was $1.4 million compared ... and $1.5 million for the third quarter of ...
(Date:3/26/2015)... The Market Element LLC, a leading ... with Designing Gig LLC to provide website design, development, ... “Forging this alliance with Designing Gig represents a pivotal ... a comprehensive, end-to-end, digital solution for our clients, which ... Chuck Miller, president of The Market Element. “For small ...
(Date:3/26/2015)... 2015 Neogen Corporation (NASDAQ: NEOG ) ... quarter of fiscal 2015, which ended Feb. 28, increased ... $6,575,000. Earnings per share in the current quarter were ... net income increased 17% over prior year to $24,142,000, ... per share, for the same period a year ago. ...
Breaking Biology Technology:Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 2Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 3Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 2Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 3Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 4Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 5Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 6Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 7The Market Element LLC and Designing Gig LLC Form Strategic Alliance 2Neogen reports 13% increase in net income 2Neogen reports 13% increase in net income 3Neogen reports 13% increase in net income 4Neogen reports 13% increase in net income 5Neogen reports 13% increase in net income 6Neogen reports 13% increase in net income 7Neogen reports 13% increase in net income 8
... Today sees the announcement of full details of how an ... at the forefront of research into ,wonder material, graphene. Also ... and research technology. 200 times stronger than ... strongest and thinnest material ever measured, and also the world,s ...
... PARK, Calif., Feb. 2, 2012 Auxogyn, Inc., a privately-held ... close of the final tranche of its Series A financing, ... was placed in May 2010, and investors in the round ... Serono Ventures. "Over the course of the last ...
... Feb. 2, 2012   Reportlinker.com announces that a ... its catalogue: U.S. Tissue ... The scope of this research ... companies in the wound care and surgery ...
Cached Biology Technology:New investment aims to establish the UK as a global graphene research hub 2New investment aims to establish the UK as a global graphene research hub 3Auxogyn Completes $20 Million In Series A Funding 2Auxogyn Completes $20 Million In Series A Funding 3U.S. Tissue Engineering Markets 2U.S. Tissue Engineering Markets 3
(Date:3/20/2015)... Research and Markets ( http://www.researchandmarkets.com/research/4stcg3/india_sensors ... "India Sensors Market Forecast and Opportunities 2020" ... market is projected to grow at a CAGR ... automotive, industrial and healthcare sectors are the key ... addition, adoption of MEMS technology in sensors is ...
(Date:3/20/2015)... 19, 2015 Research and Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ... - Global Strategic Business Report" report to their offering. ... Biometrics in US$ Thousands. The report provides separate comprehensive analytics ... Japan , Europe , ... Latin America . Annual estimates ...
(Date:3/17/2015)... MedNet Solutions , a global ... management systems, is pleased to announce that company ... in Clinical Trials Southeast conference – March 24-25 ... forum for MedNet to showcase iMedNet , ... eClinical technology platform. We strongly encourage ...
Breaking Biology News(10 mins):India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2
... Arsenic from treated lumber used in decks, utility poles ... decades to come, possibly threatening groundwater, according to two ... University of Miami, the University of Florida and Florida ... or CCA-treated wood, from a real deck as well ...
... , The recent discovery of a 90-million-year-old dinosaur ... carnivorous theropods that includes Velociraptor and is closely ... thought. Rather than originating during the Cretaceous, dromaeosaurs ... possibly as far back as 180 million years ...
... weapons used by our immune system to absorb and ... defence mechanism and even multiply within the macrophages. Cell ... a strategy in a recently publication in the journal ... findings reveal that the pathogens escape the 'stomach' of ...
Cached Biology News:Researchers: Treated wood poses long-term threat 2Researchers: Treated wood poses long-term threat 3Newly discovered birdlike dinosaur is oldest raptor ever found in South America 2Newly discovered birdlike dinosaur is oldest raptor ever found in South America 3Newly discovered birdlike dinosaur is oldest raptor ever found in South America 4Dangerous tricksters: Some bacterie use immune cells to reproduce 2Dangerous tricksters: Some bacterie use immune cells to reproduce 3
... intended for laboratory research use only. ... buffered formalin and embedded in paraffin. ... certified pathologists. Tissue cores were removed ... a new recipient paraffin block, in an ...
... kit contains all the reagents required for ... c reductase activity in cell and tissue ... (ER)]. It has been tested on samples ... kidney, brain, spleen, and heart muscle from ...
... Cell Sets Sets of pET host ... The most common method for transformation ... is to use chemically competent cells. Although ... laboratory, greater efficiency, reproducibility and convenience are ...
The Saturn 2200 answers your GC/MS questions with the CP-3800 GC and the 2000 Series Ion Trap MS! These components create a platform for the worlds most versatile GC and flexible MS. Both deliver une...
Biology Products: